|
|
News Breaks | | | | January 7, 2013 | | 10:44 EDT |  | RPRX | Repros expects to report results for Phase 2 vaginal Proellex study in 1Q13
Sees fully enrolling 1 year Dexa study in Q1. Expects to request Androxal pre-NDA meeting with FDA for 1Q14 in 4Q13. Comments from slides that will be presented at the 2013 Biotech Showcase Conference. | |
|
News For RPRX From The Last 14 Days Check below for free stories on RPRX the last two weeks. |
|
|
| May 10, 2013 | | 09:26 EDT |  | RPRX | Repros Therapeutics reports Q1 EPS (41c), consensus (35c)
 Subscribe for More Information | |
|
|
|
|
|
|
